The impact of previous tuberculosis history on T-SPOT.TB® interferon-gamma release assay results

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 4, 2011, Pages 510-516

  Kim, H J ^a   Yoon, H I ^a   Park, K U ^b   Lee, C T ^a   Lee, Jae Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

IGRA; T SPOT.TB; Tuberculosis

Indexed keywords

GAMMA INTERFERON; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HUMAN; INTERFERON PRODUCTION; KOREA; LATENT TUBERCULOSIS; LUNG FIBROSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS; YOUNG ADULT;

EID: 79952810973     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0520     Document Type: Article

References (27)

1. Andersen P, Munk M E, Pollock J M, Doherty T M. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
2. Lalvani A, Pathan A A, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T-cells. Am J Respir Crit Care Med 2001; 163: 824-828.
3. Pai M, Riley L W, Colford J M Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-776.
4. Mack U, Migliori G B, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
5. Mazurek G H, Jereb J, Lobue P, Iademarco M F, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.
6. Zellweger J P, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 2005; 9: 1242-1247. (Pubitemid 41735604)
7. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328-1334.
8. Lee J Y, Choi H J, Park I N, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28: 24-30.
9. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T-cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004; 38: 754-756. (Pubitemid 38333874)
10. Aiken A M, Hill P C, Fox A, et al. Reversion of the ELISpot test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006; 6: 66.
11. Pathan A A, Wilkinson K A, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001; 167: 5217-5225.
12. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect 2009; 58: 197-204.
13. Kobashi Y, Mouri K, Yagi S, et al. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Scand J Infect Dis 2008; 40: 629-634.
14. Ulrichs T, Anding R, Kaufmann S H, Munk M E. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 2000; 4: 1181-1183. (Pubitemid 32046299)
15. Wu-Hsieh B A, Chen C K, Chang J H, et al. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 2001; 33: 1336-1340. (Pubitemid 32955183)
16. Ferrand R A, Bothamley G H, Whelan A, Dockrell H M. I nterferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 2005; 9: 1034-1039. (Pubitemid 41549192)
17. Pai M, Joshi R, Bandyopadhyay M, et al. Sensitivity of a wholeblood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 2007; 35: 98-103. (Pubitemid 46536774)
18. Bosshard V, Roux-Lombard P, Perneger T, et al. Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis? Respir Med 2009; 103: 30-34.
19. Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis 2009; 9: 23.
20. Kang Y A, Lee H W, Hwang S S, et al. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007; 132: 959-965.
21. Janssens J P, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J 2007; 30: 722-728.
22. Barry C E III, Boshoff H I, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7: 845-855.
23. Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 2004; 38: 757-759.
24. Leyten E M, Mulder B, Prins C, et al. Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposure. J Clin Microbiol 2006; 44: 1197-1201.
25. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
26. Sprent J, Surh C D. T-cell memory. Annu Rev Immunol 2002; 20: 551-579.
27. Kaech S M, Wherry E J, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2: 251-262. (Pubitemid 37323225)